FEZF1 and non-small cell lung carcinoma: After adjusting for age, gender, smoking status, and NSE expression, results showed that the risk of NSCLC in the high-FEZF1-AS1 level group was notably increased (adjusted OR = 2.42; 95% CI = 1.23–4.76).